Ghent, Belgium

Kathleen Camilla Telesphore Alida Maria Piens



 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Gent, BE (2016)
  • Ghent, BE (2016 - 2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kathleen Camilla Telesphore Alida Maria Piens: Innovator in Molecular Treatments

Introduction

Kathleen Camilla Telesphore Alida Maria Piens is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of molecular treatments, particularly in relation to genetic disorders. With a total of 8 patents, her work has garnered attention for its innovative approaches to complex medical challenges.

Latest Patents

Among her latest patents is a groundbreaking document titled "Methods and materials for treatment of Pompe's disease." This patent relates to molecular complexes that possess acid alpha-glucosidase activity, enhanced for better transport into mammalian cells. Another notable patent is "Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose," which describes methods and genetically engineered cells that are useful for uncapping a mannose-6-phosphate residue on an oligosaccharide.

Career Highlights

Throughout her career, Kathleen has worked with various companies, including Oxyrane UK Limited and Vib Vzw. Her innovative research has positioned her as a key figure in the development of treatments for genetic disorders, showcasing her dedication to advancing medical science.

Collaborations

Kathleen has collaborated with notable coworkers such as Wouter Vervecken and Gwenda Noëlla Pynaert. These partnerships have further enriched her research and contributed to her success in the field.

Conclusion

Kathleen Camilla Telesphore Alida Maria Piens is a trailblazer in the realm of molecular treatments, with a focus on genetic disorders. Her patents and collaborations reflect her commitment to innovation and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…